Utama › Penyakit Arteri Koronari › New Jersey
Kajian klinikal Penyakit Arteri Koronari di New Jersey
15 kajian untuk Penyakit Arteri Koronari sedang mencari peserta di lokasi di New Jersey.
Bandar di New Jersey
Teks kajian rasmi (Bahasa Inggeris)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Virtua Health, Camden
Mengambil peserta
Umur 18 hingga 90 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07296744A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- HACKENSACK MERIDIAN HEALTH, Inc, Jersey City
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07286578Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Advanced Heart Care LLC, Bridgewater
- Cardiovascular Associates of the Delaware Valley, Elmer
- Advanced Heart and Vascular Institute Of Hunterdon, Flemington
- dan 3 lagi
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06909565IVUS CHIP UPP Registry
- Barnabas Health, Jersey City
- Virtua Health, Marlton
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06625801Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961Product Surveillance Registry
- Camden
- Marlton
- Morristown
- dan 2 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT01524276REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
- Englewood Hospital, Englewood
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06399705REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
- Englewood Hospital, Englewood
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06399692Prevail Global Study
- Virtua Our Lady of Lourdes Hospital, Camden
- The Valley Hospital, Paramus
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Apr 2026 · NCT06535854Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Englewood Health, Englewood
- Newark Beth Israel Medical Center, Newark
- The Valley Hospital, Ridgewood
Mengambil peserta
Umur 18 ke atas · Wanita · Dikemas kini 1 Apr 2026 · NCT04124120MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- Atlanticare Regional Medical Center, Pomona
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Sep 2025 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Our Lady of Lourdes, Camden
- Valley Hospital, Ridgewood
Mengambil peserta
Semua umur · Semua jantina · Dikemas kini 24 Jul 2025 · NCT04634240Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- RWJ Barnabas Health, Jersey City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Jun 2025 · NCT05701358PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
- Deborah Heart and Lung Center, Browns Mills
Mengambil peserta
Umur 18 hingga 90 · Semua jantina · Dikemas kini 13 Jun 2025 · NCT06445608MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- AtlantiCare Regional Medical Center, Pomona
Mengambil peserta
Umur 18 hingga 110 · Semua jantina · Dikemas kini 25 Feb 2025 · NCT05908331Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.